La diffusion désormais sans frontières des médicaments anti-obésité est surveillée de près par ceux qui doivent dispenser ces thérapies. The Order of Pharmacists of the province of Rome has sent a report to the Ministry of Health, AIFA, Agcm, Nas and the Medical Association of Rome and its province. The subject of the report is « on distortion phenomena, media promotion, anomalous discount policies and dispensing relating to Mounjaro* and similar receptor agonists ». The Order of Pharmacists of the province of Rome, in the person of the president Giuseppe Guaglianone, submits in the letter – which Adnkronos Salute has had the opportunity to view – « a situation of growing criticality which is affecting the distribution, prescription and dispensing chain of ethical drugs with metabolic action – with particular reference to Mounjaro (tirzepatide) and receptor analogues – the management of which is recording deviations worthy of careful institutional evaluation ».
« In recent months we have witnessed strong media and commercial pressure, fueled by online platforms and social networks, which tends to trivialize complex pharmacological treatments with significant clinical impact – indicated in the treatment of type 2 diabetes mellitus and obesity or overweight in the presence of specific conditions – reducing them to mere aesthetic or customary tendencies. This circumstance could lead to worrying distortions on the market and on regular continuity of care, exposing the sector to the logic of speculative hoarding and competition dynamics commercial des questions sans rapport avec la mission sanitaire », souligne le président.
Le ministère de la Santé a répondu au rapport en envoyant une communication aux régions. « It represents the opportunity for checks to be carried out in relation to the prescription and dispensing to the public of ethical drugs with metabolic action with particular reference to Mounjaro* (Tirzepatide) and receptor analogues ».
La Région Lombardie est intervenue quelques jours plus tard. « The pharmaceutical services and epidemiological services of the ATS are proceeding with analyzes of prescriptive appropriateness on anti-LPG-1 receptor antagonist drugs with a procedure shared at regional management level, in order to verify the drivers behind the significant growth in consumption by the NHS at both a national and regional level », reports a circular from the Lombardy Region to the provincial medical orders, Federfarma Lombardia, Assofarm Lombardia, United Pharmacies and primary care departments of the Asst.
